ALYSSA DILLON: Open Payments
NPI 1144003062 · GAHANNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 44 payments from 15 companies in 2025. Trend: 2023 $174 · 2024 $851 · 2025 $1,729
Food & beverage: $1,693Education: $36
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $382 |
| IMMUNITYBIO, INC. | 3 | $336 |
| Janssen Biotech, Inc. | 2 | $173 |
| TOLMAR, INC. | 2 | $146 |
| 180 Medical, Inc. | 5 | $121 |
| Medtronic, Inc. | 4 | $110 |
| Astellas Pharma US Inc | 1 | $98 |
| Endo USA, Inc. | 5 | $94 |
| ConvaTec Inc. | 2 | $61 |
| Boston Scientific Corporation | 2 | $54 |
Products named: GEMTESA, ANKTIVA, ERLEADA, Xtandi, AVEED, RYBREVANT, GENTLECATH GLIDE, Axonics.
Industry payments across OH — which companies pay providers there.
